Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
M1 Macrophage-Engineered Vesicles Have Anti-Cancer Activity in Ovarian Cancer.
Journal: Cancer nanotechnology
Published: January 12, 2026
Cisplatin-Loaded M1 Macrophage-Derived Vesicles Have Anti-Cancer Activity in Osteosarcoma.
Journal: Cells
Published: September 08, 2025
Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies.
Journal: Molecular therapy oncolytics
Published: March 13, 2023
Bioavailability of the tumor necrosis factor alpha/regulated on activation, normal T cell expressed and secreted (RANTES) biosystem inside the gestational sac during the pre-immune stages of embryo development.
Journal: Journal of perinatal medicine
Published: November 09, 2022
Human macrophage-engineered vesicles for utilization in ovarian cancer treatment.
Journal: Frontiers in oncology
Published: September 12, 2022
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy.
Journal: Cancers
Published: March 21, 2022
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer.
Journal: Biomedicines
Published: December 17, 2020
Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?
Journal: Journal of robotic surgery
Published: May 26, 2020
Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study.
Journal: Obstetrics & gynecology science
Published: May 29, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026